The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression

Table 1

Demographic characteristic of patients.

Age	Range 41–96	Mean 59
Staging FIGO	IIc–IV
Histology	Serous adenocarcinoma	𝑛=35
	Mucinous adenocarcinoma	𝑛=2
	Clear cell carcinoma	𝑛=1
	Endometrial carcinoma	𝑛=2
Surgical treatment	Optimal cytoreduction	𝑛=7
	Residual disease	𝑛=28
Chemotherapy treatment (any before the fluid collection)	Yes	𝑛=28
	No	𝑛=7
Chemotherapy treatment in the last 4 weeks	Yes	𝑛=19
	No	𝑛=16